Main Street Investment Advisors LLC Abb Vie Inc. Transaction History

Main Street Investment Advisors LLC

$730 Million
Q3 2024

A detailed history of Main Street Investment Advisors LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Main Street Investment Advisors LLC holds 68,158 shares of ABBV stock, worth $12.4 Million. This represents 1.84% of its overall portfolio holdings.

Number of Shares

68,158

Previous 74,623 8.66%

Holding current value

$12.4 Million

Previous $12.8 Million 5.16%

% of portfolio

1.84%

Previous 1.56%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$163.84 - $199.33 $1.06 Million - $1.29 Million	-6,465 Reduced 8.66%	68,158 $13.5 Million
Q2 2024 Aug 06, 2024	SELL	$154.79 - $180.76 $5.37 Million - $6.27 Million	-34,675 Reduced 31.73%	74,623 $12.8 Million
Q1 2024 May 08, 2024	SELL	$159.82 - $182.1 $555,214 - $632,615	-3,474 Reduced 3.08%	109,298 $19.9 Million
Q4 2023 Feb 09, 2024	SELL	$137.6 - $154.97 $44,720 - $50,365	-325 Reduced 0.29%	112,772 $17.5 Million
Q3 2023 Feb 16, 2024	BUY	$133.59 - $154.65 $320,616 - $371,160	2,400 Added 2.13%	115,172 $17.2 Million
Q3 2023 Oct 31, 2023	SELL	$133.59 - $154.65 $475,313 - $550,244	-3,558 Reduced 3.05%	113,097 $16.9 Million
Q2 2023 Feb 16, 2024	BUY	$132.51 - $164.9 $568,202 - $707,091	4,288 Added 3.8%	117,060 $15.8 Million
Q2 2023 Jul 21, 2023	SELL	$132.51 - $164.9 $453,051 - $563,793	-3,419 Reduced 2.85%	116,655 $15.7 Million
Q1 2023 Apr 28, 2023	BUY	$144.61 - $166.54 $477,213 - $549,582	3,300 Added 2.83%	120,074 $19.1 Million
Q4 2022 Feb 02, 2023	SELL	$138.31 - $165.87 $712,158 - $854,064	-5,149 Reduced 4.22%	116,774 $18.9 Million
Q2 2022 Aug 03, 2022	SELL	$137.62 - $174.96 $2.58 Million - $3.28 Million	-18,765 Reduced 13.34%	121,923 $18.7 Million
Q1 2022 May 02, 2022	SELL	$131.98 - $163.75 $252,873 - $313,745	-1,916 Reduced 1.34%	140,688 $22.8 Million
Q4 2021 Feb 01, 2022	SELL	$107.43 - $135.93 $91,745 - $116,084	-854 Reduced 0.6%	142,604 $19.3 Million
Q3 2021 Nov 08, 2021	BUY	$106.4 - $120.78 $3.56 Million - $4.04 Million	33,460 Added 30.42%	143,458 $15.5 Million
Q2 2021 Aug 05, 2021	BUY	$105.21 - $117.21 $59,759 - $66,575	568 Added 0.52%	109,998 $12.4 Million
Q1 2021 May 07, 2021	SELL	$102.3 - $112.62 $157,439 - $173,322	-1,539 Reduced 1.39%	109,430 $11.8 Million
Q4 2020 Feb 09, 2021	SELL	$80.49 - $108.67 $958,555 - $1.29 Million	-11,909 Reduced 9.69%	110,969 $11.9 Million
Q3 2020 Nov 09, 2020	SELL	$85.91 - $100.83 $1.46 Million - $1.72 Million	-17,047 Reduced 12.18%	122,878 $10.8 Million
Q2 2020 Aug 14, 2020	BUY	$73.37 - $98.18 $1.13 Million - $1.51 Million	15,419 Added 12.38%	139,925 $13.7 Million
Q1 2020 May 11, 2020	BUY	$64.5 - $97.79 $537,994 - $815,666	8,341 Added 7.18%	124,506 $9.49 Million
Q4 2019 Feb 03, 2020	BUY	$72.13 - $90.25 $386,977 - $484,191	5,365 Added 4.84%	116,165 $10.3 Million
Q3 2019 Oct 29, 2019	SELL	$62.98 - $75.72 $314 - $378	-5 Reduced -0.0%	110,800 $8.39 Million
Q2 2019 Jul 18, 2019	BUY	$65.7 - $83.98 $97,498 - $124,626	1,484 Added 1.36%	110,805 $8.06 Million
Q1 2019 May 10, 2019	BUY	$77.14 - $90.79 $565,050 - $665,036	7,325 Added 7.18%	109,321 $8.81 Million
Q4 2018 Feb 13, 2019	BUY	$77.85 - $96.01 $33,942 - $41,860	436 Added 0.43%	101,996 $9.4 Million
Q3 2018 Oct 15, 2018	BUY	$88.91 - $98.84 $1.33 Million - $1.47 Million	14,916 Added 17.22%	101,560 $9.61 Million
Q2 2018 Jul 30, 2018	BUY	$89.78 - $106.23 $314,858 - $372,548	3,507 Added 4.22%	86,644 $8.03 Million
Q1 2018 Apr 23, 2018	BUY	$92.01 - $123.21 $5,612 - $7,515	61 Added 0.07%	83,137 $7.87 Million
Q4 2017 Feb 15, 2018	BUY	$89.56 - $98.21 $7.44 Million - $8.16 Million	83,076	83,076 $8.03 Million

Others Institutions Holding ABBV

# of Institutions

3,854

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $320B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Main Street Investment Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Main Street Investment Advisors LLC with notifications on news.

Account

Main Street Investment Advisors LLC Abb Vie Inc. Transaction History